These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 39363643)
1. Multistep modeling applied to a Malaysian ALS registry. Capelle DP; Sabirin W; Zulhairy-Liong NA; Edgar S; Goh KJ; Ahmad-Annuar A; Shahrizaila N Amyotroph Lateral Scler Frontotemporal Degener; 2024 Oct; ():1-5. PubMed ID: 39363643 [TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis as a multi-step process: an Australia population study. Vucic S; Westeneng HJ; Al-Chalabi A; Van Den Berg LH; Talman P; Kiernan MC Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):532-537. PubMed ID: 31284763 [No Abstract] [Full Text] [Related]
3. Previous psychiatric disorders in the multistep hypothesis of amyotrophic lateral sclerosis: a South Korean population study. Choi SJ; Park CHK; Hong YH; Sung JJ Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):601-607. PubMed ID: 35164606 [No Abstract] [Full Text] [Related]
4. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Al-Chalabi A; Calvo A; Chio A; Colville S; Ellis CM; Hardiman O; Heverin M; Howard RS; Huisman MHB; Keren N; Leigh PN; Mazzini L; Mora G; Orrell RW; Rooney J; Scott KM; Scotton WJ; Seelen M; Shaw CE; Sidle KS; Swingler R; Tsuda M; Veldink JH; Visser AE; van den Berg LH; Pearce N Lancet Neurol; 2014 Nov; 13(11):1108-1113. PubMed ID: 25300936 [TBL] [Abstract][Full Text] [Related]
5. ALS is a multistep process in South Korean, Japanese, and Australian patients. Vucic S; Higashihara M; Sobue G; Atsuta N; Doi Y; Kuwabara S; Kim SH; Kim I; Oh KW; Park J; Kim EM; Talman P; Menon P; Kiernan MC; Neurology; 2020 Apr; 94(15):e1657-e1663. PubMed ID: 32071166 [TBL] [Abstract][Full Text] [Related]
6. The multistep hypothesis of ALS revisited: The role of genetic mutations. Chiò A; Mazzini L; D'Alfonso S; Corrado L; Canosa A; Moglia C; Manera U; Bersano E; Brunetti M; Barberis M; Veldink JH; van den Berg LH; Pearce N; Sproviero W; McLaughlin R; Vajda A; Hardiman O; Rooney J; Mora G; Calvo A; Al-Chalabi A Neurology; 2018 Aug; 91(7):e635-e642. PubMed ID: 30045958 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease, psychiatric diagnosis and sex differences in the multistep hypothesis of amyotrophic lateral sclerosis. Garton FC; Trabjerg BB; Wray NR; Agerbo E Eur J Neurol; 2021 Feb; 28(2):421-429. PubMed ID: 32978838 [TBL] [Abstract][Full Text] [Related]
8. Natural history and clinical features of ALS in Malaysia. Abdul Aziz NA; Toh TH; Goh KJ; Loh EC; Capelle DP; Abdul Latif L; Leow AH; Yim CC; Zainal Abidin MF; Ruslan SR; Shahrizaila N Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):108-116. PubMed ID: 33084408 [TBL] [Abstract][Full Text] [Related]
10. Irish Amyotrophic Lateral Sclerosis Incidence: Age, Period, and Cohort Effects Using a Partial Least Squares Regression Model. McFarlane R; Heverin M; Walsh C; Hardiman O Neurology; 2024 Jun; 102(11):e209391. PubMed ID: 38728654 [TBL] [Abstract][Full Text] [Related]
11. The common incidence-age multistep model of neurodegenerative diseases revisited: wider general age range of incidence corresponds to fewer disease steps. Gerovska D; Araúzo-Bravo MJ Cell Biosci; 2022 Jan; 12(1):11. PubMed ID: 35093175 [TBL] [Abstract][Full Text] [Related]
13. A Meta-Analysis Study of SOD1-Mutant Mouse Models of ALS to Analyse the Determinants of Disease Onset and Progression. Ciuro M; Sangiorgio M; Leanza G; Gulino R Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613659 [TBL] [Abstract][Full Text] [Related]
14. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016. Mehta P; Raymond J; Punjani R; Larson T; Han M; Bove F; Horton DK Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):378-382. PubMed ID: 35023792 [No Abstract] [Full Text] [Related]
15. History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010-2018. Raymond J; Mehta P; Larson T; Factor-Litvak P; Davis B; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):535-544. PubMed ID: 33896281 [No Abstract] [Full Text] [Related]
16. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia. Uenal H; Rosenbohm A; Kufeldt J; Weydt P; Goder K; Ludolph A; Rothenbacher D; Nagel G; PLoS One; 2014; 9(4):e93932. PubMed ID: 24722455 [TBL] [Abstract][Full Text] [Related]
17. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: a ten year follow up study. Cabona C; Ferraro PM; Scialò C; Bandettini Di Poggio M; Novi G; Gemelli C; Vignolo M; Rao F; Capovilla M; Marogna M; Mandich P; Origone P; Schenone A; Caponnetto C Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):104-111. PubMed ID: 37737151 [TBL] [Abstract][Full Text] [Related]
18. Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018. Punjani R; Larson TC; Wagner L; Davis B; Horton DK; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):203-211. PubMed ID: 36200180 [TBL] [Abstract][Full Text] [Related]
19. Incidence of amyotrophic lateral sclerosis in Chile. Lillo P; Zitko P; Godoy-Reyes G; Asenjo G; Sáez D; Cea G; Navarrete P; Valenzuela D; Hughes R; Heverin M; Logroscino G; Hardiman O Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):528-532. PubMed ID: 38506473 [TBL] [Abstract][Full Text] [Related]
20. Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients. Piccoli T; Castro F; La Bella V; Meraviglia S; Di Simone M; Salemi G; Dieli F; Spataro R BMC Neurol; 2023 Jun; 23(1):222. PubMed ID: 37296379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]